Cargando…

Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae

The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Chukwudulue, Uche M., Barger, Natalia, Dubovis, Michael, Luzzatto Knaan, Tal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672036/
https://www.ncbi.nlm.nih.gov/pubmed/37999393
http://dx.doi.org/10.3390/md21110569
_version_ 1785140296434057216
author Chukwudulue, Uche M.
Barger, Natalia
Dubovis, Michael
Luzzatto Knaan, Tal
author_facet Chukwudulue, Uche M.
Barger, Natalia
Dubovis, Michael
Luzzatto Knaan, Tal
author_sort Chukwudulue, Uche M.
collection PubMed
description The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms whose natural products are yet to be explored. Among these underexplored marine organisms are macroalgae and their symbiotic microbes, such as Bacillota, a phylum of mostly Gram-positive bacteria previously known as Firmicutes. Macroalgae-associated Bacillota often produce chemical compounds that protect them and their hosts from competitive and harmful rivals. Here, we summarised the natural products made by macroalgae-associated Bacillota and their pharmacological properties. We discovered that these Bacillota are efficient producers of novel biologically active molecules. However, only a few macroalgae had been investigated for chemical constituents of their Bacillota: nine brown, five red and one green algae. Thus, Bacillota, especially from the marine habitat, should be investigated for potential pharmaceutical leads. Moreover, additional diverse biological assays for the isolated molecules of macroalgae Bacillota should be implemented to expand their bioactivity profiles, as only antibacterial properties were tested for most compounds.
format Online
Article
Text
id pubmed-10672036
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106720362023-10-30 Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae Chukwudulue, Uche M. Barger, Natalia Dubovis, Michael Luzzatto Knaan, Tal Mar Drugs Review The shift from the terrestrial to the marine environment to discover natural products has given rise to novel bioactive compounds, some of which have been approved for human medicine. However, the ocean, which makes up nearly three-quarters of the Earth’s surface, contains macro- and microorganisms whose natural products are yet to be explored. Among these underexplored marine organisms are macroalgae and their symbiotic microbes, such as Bacillota, a phylum of mostly Gram-positive bacteria previously known as Firmicutes. Macroalgae-associated Bacillota often produce chemical compounds that protect them and their hosts from competitive and harmful rivals. Here, we summarised the natural products made by macroalgae-associated Bacillota and their pharmacological properties. We discovered that these Bacillota are efficient producers of novel biologically active molecules. However, only a few macroalgae had been investigated for chemical constituents of their Bacillota: nine brown, five red and one green algae. Thus, Bacillota, especially from the marine habitat, should be investigated for potential pharmaceutical leads. Moreover, additional diverse biological assays for the isolated molecules of macroalgae Bacillota should be implemented to expand their bioactivity profiles, as only antibacterial properties were tested for most compounds. MDPI 2023-10-30 /pmc/articles/PMC10672036/ /pubmed/37999393 http://dx.doi.org/10.3390/md21110569 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Chukwudulue, Uche M.
Barger, Natalia
Dubovis, Michael
Luzzatto Knaan, Tal
Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title_full Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title_fullStr Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title_full_unstemmed Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title_short Natural Products and Pharmacological Properties of Symbiotic Bacillota (Firmicutes) of Marine Macroalgae
title_sort natural products and pharmacological properties of symbiotic bacillota (firmicutes) of marine macroalgae
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672036/
https://www.ncbi.nlm.nih.gov/pubmed/37999393
http://dx.doi.org/10.3390/md21110569
work_keys_str_mv AT chukwudulueuchem naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae
AT bargernatalia naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae
AT dubovismichael naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae
AT luzzattoknaantal naturalproductsandpharmacologicalpropertiesofsymbioticbacillotafirmicutesofmarinemacroalgae